Targeting	0	9	O
TNF	10	13	B-Gene_or_gene_product
for	14	17	O
Treatment	18	27	O
of	28	30	O
Cancer	31	37	B-Pathological_formation
and	38	41	O
Autoimmunity	42	54	O
.	54	55	O

Tumor	57	62	B-Gene_or_gene_product
necrosis	63	71	I-Gene_or_gene_product
factor	72	78	I-Gene_or_gene_product
-	78	79	I-Gene_or_gene_product
alpha	79	84	I-Gene_or_gene_product
(	85	86	O
TNF	86	89	B-Gene_or_gene_product
-	89	90	I-Gene_or_gene_product
alpha	90	95	I-Gene_or_gene_product
)	95	96	O
was	97	100	O
first	101	106	O
isolated	107	115	O
two	116	119	O
decades	120	127	O
ago	128	131	O
as	132	134	O
a	135	136	O
macrophageproduced	137	155	O
protein	156	163	O
that	164	168	O
can	169	172	O
effectively	173	184	O
kill	185	189	O
tumor	190	195	B-Cell
cells	196	201	I-Cell
.	201	202	O

TNF	203	206	B-Gene_or_gene_product
-	206	207	I-Gene_or_gene_product
alpha	207	212	I-Gene_or_gene_product
is	213	215	O
also	216	220	O
an	221	223	O
essential	224	233	O
component	234	243	O
of	244	246	O
the	247	250	O
immune	251	257	O
system	258	264	O
and	265	268	O
is	269	271	O
required	272	280	O
for	281	284	O
hematopoiesis	285	298	O
,	298	299	O
for	300	303	O
protection	304	314	O
from	315	319	O
bacterial	320	329	O
infection	330	339	O
and	340	343	O
for	344	347	O
immune	348	354	B-Cell
cell	355	359	I-Cell
-	359	360	O
mediated	360	368	O
cytotoxicity	369	381	O
.	381	382	O

Extensive	383	392	O
research	393	401	O
,	401	402	O
however	403	410	O
,	410	411	O
has	412	415	O
revealed	416	424	O
that	425	429	O
TNF	430	433	B-Gene_or_gene_product
-	433	434	I-Gene_or_gene_product
alpha	434	439	I-Gene_or_gene_product
is	440	442	O
one	443	446	O
of	447	449	O
the	450	453	O
major	454	459	O
players	460	467	O
in	468	470	O
tumor	471	476	B-Pathological_formation
initiation	477	487	O
,	487	488	O
proliferation	489	502	O
,	502	503	O
invasion	504	512	O
,	512	513	O
angiogenesis	514	526	O
and	527	530	O
metastasis	531	541	O
.	541	542	O

The	543	546	O
proinflammatory	547	562	O
activities	563	573	O
link	574	578	O
TNF	579	582	B-Gene_or_gene_product
-	582	583	I-Gene_or_gene_product
alpha	583	588	I-Gene_or_gene_product
with	589	593	O
a	594	595	O
wide	596	600	O
variety	601	608	O
of	609	611	O
autoimmune	612	622	O
diseases	623	631	O
,	631	632	O
including	633	642	O
psoriasis	643	652	O
,	652	653	O
inflammatory	654	666	O
bowel	667	672	B-Organ
disease	673	680	O
,	680	681	O
rheumatoid	682	692	O
arthritis	693	702	O
,	702	703	O
systemic	704	712	O
sclerosis	713	722	O
,	722	723	O
systemic	724	732	O
lupus	733	738	O
erythematosus	739	752	O
,	752	753	O
multiple	754	762	O
sclerosis	763	772	O
,	772	773	O
diabetes	774	782	O
and	783	786	O
ankylosing	787	797	O
spondylitis	798	809	O
.	809	810	O

Systemic	811	819	O
inhibitors	820	830	O
of	831	833	O
TNF	834	837	B-Gene_or_gene_product
such	838	842	O
as	843	845	O
etanercept	846	856	B-Drug_or_compound
(	857	858	O
Enbrel	858	864	B-Drug_or_compound
)	864	865	O
(	866	867	O
a	867	868	O
soluble	869	876	O
TNF	877	880	B-Gene_or_gene_product
receptor	881	889	O
)	889	890	O
and	891	894	O
infliximab	895	905	B-Drug_or_compound
(	906	907	O
Remicade	907	915	B-Drug_or_compound
)	915	916	O
and	917	920	O
adalimumab	921	931	B-Drug_or_compound
(	932	933	O
Humira	933	939	B-Drug_or_compound
)	939	940	O
(	941	942	O
anti	942	946	O
-	946	947	O
TNF	947	950	B-Gene_or_gene_product
antibodies	951	961	O
)	961	962	O
have	963	967	O
been	968	972	O
approved	973	981	O
for	982	985	O
the	986	989	O
treatment	990	999	O
inflammatory	1000	1012	O
bowel	1013	1018	B-Organ
disease	1019	1026	O
,	1026	1027	O
psoriasis	1028	1037	O
and	1038	1041	O
rheumatoid	1042	1052	O
arthritis	1053	1062	O
.	1062	1063	O

These	1064	1069	O
drugs	1070	1075	O
,	1075	1076	O
however	1077	1084	O
,	1084	1085	O
exhibit	1086	1093	O
severe	1094	1100	O
side	1101	1105	O
effects	1106	1113	O
and	1114	1117	O
are	1118	1121	O
expensive	1122	1131	O
.	1131	1132	O

Hence	1133	1138	O
orally	1139	1145	O
active	1146	1152	O
blockers	1153	1161	O
of	1162	1164	O
TNF	1165	1168	B-Gene_or_gene_product
-	1168	1169	I-Gene_or_gene_product
alpha	1169	1174	I-Gene_or_gene_product
that	1175	1179	O
are	1180	1183	O
safe	1184	1188	O
,	1188	1189	O
efficacious	1190	1201	O
and	1202	1205	O
inexpensive	1206	1217	O
are	1218	1221	O
urgently	1222	1230	O
needed	1231	1237	O
.	1237	1238	O

Numerous	1239	1247	O
products	1248	1256	O
from	1257	1261	O
fruits	1262	1268	O
,	1268	1269	O
vegetable	1270	1279	O
and	1280	1283	O
traditional	1284	1295	O
medicinal	1296	1305	O
plants	1306	1312	O
have	1313	1317	O
been	1318	1322	O
described	1323	1332	O
which	1333	1338	O
can	1339	1342	O
suppress	1343	1351	O
TNF	1352	1355	B-Gene_or_gene_product
expression	1356	1366	O
and	1367	1370	O
TNF	1371	1374	B-Gene_or_gene_product
signaling	1375	1384	O
but	1385	1388	O
their	1389	1394	O
clinical	1395	1403	O
potential	1404	1413	O
is	1414	1416	O
yet	1417	1420	O
uncertain	1421	1430	O
.	1430	1431	O

